genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2011
Mortality
News
Phase III Study Finds Eisai’s Eritoran Fails to Reduce Mortality in Severe Sepsis
News
Phase IIIb Study Confirms Benefits of Pfizer’s Inspra in New Patient Population
Cancer
NormOxys Secures $17.5M and Takes Lead Oxygen Release Enhancer into Phase I
Cancer
Cell Proliferation and Immune Response Related Genes Could Predict Melanoma Survival Rate
News
Arguments against President Obama’s Stem Cell Policies
News
Genetic Variant Identified in African Americans that Aids Survival After Heart Failure
News
Pathway that Causes Death of Premature Newborns Illuminated
News
Scientists Find Diabetes Drug Kills p53-deficient Cancer Cells
News
Diosynth Extends Commercial Supply Ageement with PDL BioPharma
1
...
4
5
6
Page 6 of 6
Scroll Up
Scroll Up
